Handelsbanken Fonder AB raised its place in Enphase Vitality, Inc. (NASDAQ:ENPH – Free Report) by 71.0% throughout the third quarter, in keeping with the corporate in its most up-to-date 13F submitting with the Securities and Change Fee (SEC). The institutional investor owned 714,364 shares of the semiconductor firm’s inventory after shopping for an extra 296,498 shares throughout the quarter. Handelsbanken Fonder AB owned 0.53% of Enphase Vitality price $80,737,000 on the finish of the latest reporting interval.
Quite a lot of different institutional buyers and hedge funds have additionally just lately added to or lowered their stakes within the firm. Northern Belief Corp grew its stake in shares of Enphase Vitality by 0.3% within the fourth quarter. Northern Belief Corp now owns 1,364,567 shares of the semiconductor firm’s inventory valued at $180,314,000 after buying an extra 3,940 shares within the final quarter. DekaBank Deutsche Girozentrale raised its place in shares of Enphase Vitality by 48.6% within the 1st quarter. DekaBank Deutsche Girozentrale now owns 88,696 shares of the semiconductor firm’s inventory valued at $10,658,000 after shopping for an extra 29,013 shares within the final quarter. Allspring World Investments Holdings LLC raised its place in shares of Enphase Vitality by 364.6% within the 1st quarter. Allspring World Investments Holdings LLC now owns 108,674 shares of the semiconductor firm’s inventory valued at $13,147,000 after shopping for an extra 85,284 shares within the final quarter. Doheny Asset Administration CA purchased a brand new stake in shares of Enphase Vitality throughout the 2nd quarter price roughly $8,095,000. Lastly, Envestnet Asset Administration Inc. boosted its place in shares of Enphase Vitality by 54.9% throughout the 2nd quarter. Envestnet Asset Administration Inc. now owns 44,510 shares of the semiconductor firm’s inventory price $4,438,000 after buying an extra 15,776 shares within the final quarter. 72.12% of the inventory is owned by institutional buyers and hedge funds.
Analysts Set New Value Targets
A number of analysis companies have weighed in on ENPH. Canaccord Genuity Group minimize their goal worth on Enphase Vitality from $150.00 to $140.00 and set a “purchase” ranking for the corporate in a analysis word on Wednesday, July twenty fourth. Roth Mkm restated a “purchase” ranking and issued a $140.00 worth goal on shares of Enphase Vitality in a analysis word on Wednesday, July twenty fourth. BMO Capital Markets lowered their worth goal on shares of Enphase Vitality from $115.00 to $114.00 and set a “market carry out” ranking for the corporate in a analysis report on Wednesday. Glj Analysis started protection on shares of Enphase Vitality in a analysis word on Tuesday, June twenty fifth. They issued a “promote” ranking and a $45.82 worth goal for the corporate. Lastly, Piper Sandler boosted their goal worth on shares of Enphase Vitality from $111.00 to $120.00 and gave the inventory a “impartial” ranking in a analysis word on Monday, July twenty second. 4 analysts have rated the inventory with a promote ranking, ten have assigned a maintain ranking and seventeen have assigned a purchase ranking to the inventory. In response to MarketBeat, the inventory has a median ranking of “Maintain” and a median goal worth of $127.17.
View Our Newest Report on ENPH
Enphase Vitality Buying and selling Down 0.8 %
Shares of Enphase Vitality inventory traded down $0.84 on Friday, hitting $105.95. 2,732,819 shares of the corporate’s inventory traded palms, in comparison with its common quantity of three,746,257. The corporate has a fifty day transferring common of $113.09 and a two-hundred day transferring common of $114.03. Enphase Vitality, Inc. has a one yr low of $73.49 and a one yr excessive of $141.63. The corporate has a market capitalization of $14.42 billion, a price-to-earnings ratio of 55.18, a price-to-earnings-growth ratio of 6.19 and a beta of 1.72. The corporate has a debt-to-equity ratio of 1.36, a present ratio of 4.23 and a fast ratio of three.90.
Enphase Vitality (NASDAQ:ENPH – Get Free Report) final introduced its quarterly earnings knowledge on Tuesday, July twenty third. The semiconductor firm reported $0.43 EPS for the quarter, lacking the consensus estimate of $0.49 by ($0.06). Enphase Vitality had a return on fairness of 17.30% and a web margin of 9.12%. The corporate had income of $303.80 million for the quarter, in comparison with analyst estimates of $309.73 million. Throughout the identical interval final yr, the enterprise earned $1.16 EPS. The enterprise’s quarterly income was down 57.3% in comparison with the identical quarter final yr. As a bunch, sell-side analysts anticipate that Enphase Vitality, Inc. will publish 1.19 earnings per share for the present yr.
About Enphase Vitality
Enphase Vitality, Inc, along with its subsidiaries, designs, develops, manufactures, and sells house vitality options for the photo voltaic photovoltaic trade in the USA and internationally. The corporate gives semiconductor-based microinverter, which converts vitality on the particular person photo voltaic module degree and combines with its proprietary networking and software program applied sciences to offer vitality monitoring and management.
See Additionally
Need to see what different hedge funds are holding ENPH? Go to HoldingsChannel.com to get the most recent 13F filings and insider trades for Enphase Vitality, Inc. (NASDAQ:ENPH – Free Report).
Obtain Information & Scores for Enphase Vitality Each day – Enter your electronic mail deal with beneath to obtain a concise day by day abstract of the most recent information and analysts’ rankings for Enphase Vitality and associated corporations with MarketBeat.com’s FREE day by day electronic mail e-newsletter.
